Picture of Guerbet SA logo

GBT Guerbet SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Momentum

Relative Strength (%)
1m+12.28%
3m+61.53%
6m+71.72%
1yr+66.48%
Volume Change (%)
10d/3m+44.54%
Price vs... (%)
52w High-2.16%
50d MA+27.94%
200d MA+64.94%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.9
PEG Ratio (f)0.3
EPS Growth (f)96.47%
Dividend Yield (f)1.64%
Valuation (ttm)IndustryMarket
Price to Book Value1.16
Price to Tang. Book1.58
Price to Free Cashflown/a
Price to Sales0.56
EV to EBITDA17.75

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-5.61%
Return on Equity-10.6%
Operating Margin-3.26%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue€m789.6816.91712.29732.07753.27789847.75-1.37%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-7.05-13.55-51.53+79.46n/an/a+96.47n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Guerbet SA EPS forecast chart

Profile Summary

Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The Company operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
January 1st, 1968
Public Since
January 15th, 1986
No. of Employees
2,839
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
12,622,444

GBT Share Price Performance

Upcoming Events for GBT

Q1 2024 Guerbet SA Corporate Sales Release

Guerbet SA Annual Shareholders Meeting

Guerbet SA Annual Shareholders Meeting

Q2 2024 Guerbet SA Corporate Sales Release

Similar to GBT

Picture of Affluent Medical SAS logo

Affluent Medical SAS

fr flag iconEuronext - Paris

Picture of Alpha MOS SA logo

Alpha MOS SA

fr flag iconEuronext - Paris

Picture of Amplitude Surgical SA logo

Amplitude Surgical SA

fr flag iconEuronext - Paris

Picture of Biomerieux SA logo

Biomerieux SA

fr flag iconEuronext - Paris

Picture of Biosynex SA logo

Biosynex SA

fr flag iconEuronext - Paris

FAQ